Proof of Concept Trial of Vamorolone in Pediatric Ulcerative Colitis

NCT04348890 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Programmatic decision

Conditions

Pediatric Ulcerative Colitis

Interventions

DRUG: Vamorolone 4% suspension for oral dosing

Sponsor

ReveraGen BioPharma, Inc.